Trial Profile
A study to evaluate the safety of rapid infusion of rituximab in patients with rheumatoid arthritis in a single community practice.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 22 Jul 2015 New trial record